CASSAVA SCIENCES INC's ticker is SAVA and the CUSIP is 14817C107. A total of 71 filers reported holding CASSAVA SCIENCES INC in Q3 2020. The put-call ratio across all filers is 0.61 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $260,000 | +8.8% | 6,227 | +61.5% | 0.00% | – |
| Q3 2021 | $239,000 | -89.4% | 3,856 | -85.4% | 0.00% | -100.0% |
| Q2 2021 | $2,252,000 | +88.9% | 26,360 | -0.9% | 0.00% | – |
| Q1 2021 | $1,192,000 | +508.2% | 26,587 | -7.5% | 0.00% | – |
| Q4 2020 | $196,000 | -40.8% | 28,750 | 0.0% | 0.00% | – |
| Q3 2020 | $331,000 | +271.9% | 28,750 | 0.0% | 0.00% | – |
| Q2 2020 | $89,000 | +64.8% | 28,750 | +118.0% | 0.00% | – |
| Q1 2020 | $54,000 | – | 13,186 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bleichroeder LP | 1,739,540 | $7,150,000 | 1.87% |
| SPHERA FUNDS MANAGEMENT LTD. | 615,000 | $2,528,000 | 0.32% |
| Worth Venture Partners, LLC | 48,535 | $200,000 | 0.12% |
| Ikarian Capital, LLC | 300,000 | $1,233,000 | 0.09% |
| Orbimed Advisors | 250,000 | $1,530,000 | 0.03% |
| Quinn Opportunity Partners LLC | 35,687 | $147,000 | 0.02% |
| BOOTHBAY FUND MANAGEMENT, LLC | 38,356 | $158,000 | 0.01% |
| Jefferies Group LLC | 80,000 | $329,000 | 0.00% |
| ClariVest Asset Management LLC | 33,403 | $137,000 | 0.00% |
| Renaissance Technologies | 653,759 | $2,687,000 | 0.00% |